133 related articles for article (PubMed ID: 17428679)
1. PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells.
Janderová-Rossmeislová L; Nováková Z; Vlasáková J; Philimonenko V; Hozák P; Hodný Z
J Struct Biol; 2007 Jul; 159(1):56-70. PubMed ID: 17428679
[TBL] [Abstract][Full Text] [Related]
2. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
3. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML.
Vaitiekunaite R; Butkiewicz D; Krześniak M; Przybyłek M; Gryc A; Snietura M; Benedyk M; Harris CC; Rusin M
Mech Ageing Dev; 2007; 128(11-12):650-61. PubMed ID: 17996922
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
6. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.
Mattsson K; Pokrovskaja K; Kiss C; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1012-7. PubMed ID: 11158586
[TBL] [Abstract][Full Text] [Related]
7. PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins.
Rökaeus N; Klein G; Wiman KG; Szekely L; Mattsson K
Oncogene; 2007 Feb; 26(7):982-92. PubMed ID: 16909106
[TBL] [Abstract][Full Text] [Related]
8. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.
Langley E; Pearson M; Faretta M; Bauer UM; Frye RA; Minucci S; Pelicci PG; Kouzarides T
EMBO J; 2002 May; 21(10):2383-96. PubMed ID: 12006491
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
11. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence.
Jiang WQ; Ringertz N
Cell Growth Differ; 1997 May; 8(5):513-22. PubMed ID: 9213441
[TBL] [Abstract][Full Text] [Related]
12. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.
Häkli M; Karvonen U; Jänne OA; Palvimo JJ
Exp Cell Res; 2005 Mar; 304(1):224-33. PubMed ID: 15707587
[TBL] [Abstract][Full Text] [Related]
13. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.
Ueno T; Eizuru Y; Katano H; Kurata T; Sata T; Irie S; Ogawa-Goto K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2806-13. PubMed ID: 16870775
[TBL] [Abstract][Full Text] [Related]
14. Functional interactions between the Epstein-Barr virus BZLF1 protein and the promyelocytic leukemia protein.
Bowling BL; Adamson AL
Virus Res; 2006 May; 117(2):244-53. PubMed ID: 16307818
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
16. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells.
Liu J; Song Y; Tian B; Qian J; Dong Y; Liu J; Liu B; Sun Z
J Biochem; 2010 Dec; 148(6):659-67. PubMed ID: 20823370
[TBL] [Abstract][Full Text] [Related]
17. c-Myc localization within the nucleus: evidence for association with the PML nuclear body.
Smith KP; Byron M; O'Connell BC; Tam R; Schorl C; Guney I; Hall LL; Agrawal P; Sedivy JM; Lawrence JB
J Cell Biochem; 2004 Dec; 93(6):1282-96. PubMed ID: 15503302
[TBL] [Abstract][Full Text] [Related]
18. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
19. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
[TBL] [Abstract][Full Text] [Related]
20. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]